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ABSTRACT The coordination environment of the type 2
(nonblue) copper in native ascorbate oxidase (L-ascorbate oxygen
oxidoreductase, EC 1.10.3.3) and of a derivative of the enzyme
having the type 1 (blue) copper reversibly bleached has been
examined by electron paramagnetic resonance (EPR) spec-
troscopy. In the gL region of the spectrum of bleached ascorbate
oxidase, a seven-line superhyperfine pattern is seen that is at-
tributed to the presence of three nitrogen donor ligands to a type
2 copper having tetragonal geometry. The superhyperfine
splitting patterns in the gil region of the EPR spectra of native
and bleached ascorbate oxidase show that as many as two
fluorides may bind to type 2 copper. Because fluoride inhibits
the enzyme competitively with respect to ascorbic acid, it is
proposed that the type 2 copper is part of the ascorbate binding
site.
Ascorbate oxidase, ceruloplasmin, and laccase form a small
group of enzymes known as the blue copper oxidases; they
catalyze the four-electron reduction of dioxygen to two mole-
cules of water (1-7). These enzymes have a minimum of four
copper atoms per protein molecule in three spectroscopically
distinct sites. A type 1 or blue copper center is characterized by
an intense (E - 5000 M-1 cm-1 per copper) absorption band
at ca. 600 nm and by an abnormally narrow copper electron
paramagnetic resonance (EPR) hyperfine structure. Absorption
bands attributable to the type 2 or nonblue coppers have not
been identified conclusively for any of the blue oxidases, so the
presence of type 2 copper is inferred from EPR measurements.
Finally, the type S or EPR nondetectable copper center has two
Cu per molecule and is associated with an intense near-UV
absorption band at ca. 330 nm.
The copper distribution in these three sites has been firmly
established only for the laccases (1-6), in which a minimal
number of each type (i.e., one each of types 1 and 2 and two of
type 3) is found. Because ceruloplasmin and ascorbate oxidase
have more than four Cu per molecule (8-12), their arrangement
has been more difficult to establish. Quantitative EPR mea-
surements on ascorbate oxidase have been interpreted in terms
of three type 1 and one type 2 coppers (10-12) with the re-
maining coppers being EPR nondetectable (type 3). Based on
the analogous values for laccase (4), the ranges of extinction
coefficients reported for ascorbate oxidase (10, 13, 14) are
consistent with two or three type 1 coppers and two type 3
copper units. The presence of two apparently identical subunits
(13) complicates the picture because it is inconsistent with an
odd number of either type 1 or type 2 sites.
Considerable progress has been made in determining the
coordination geometry and ligands of the type 1 center (15-25).
Determination of the geometry and ligands in the type 2 and
type 3 copper centers has been much more difficult. Because
of the overlap of EPR, circular dichroism (CD), and optical
absorption spectra arising from the type 1 and type 2 coppers,
selective removal or reduction of the type 1 center is required
in order to study the properties of the type 2 site when both
normally appear in conjunction. Our recent work on modified
forms of ceruloplasmin (21, 26) is an example of this ap-
proach.
We have now investigated the EPR properties of an ascorbate
oxidase derivative having the type 1 sites reversible bleached
through treatment with nitric oxide (12, 27). In addition, be-
cause the inhibition studies by Mondovi et al. (28) and by
Strothkamp and Dawson (29) have implicated type 2 copper
as an anion binding site in ascorbate oxidase, we have also ex-
amined the effect of added fluoride on the EPR spectra of the
native enzyme and the NO-treated derivative.
MATERIALS AND METHODS
Purification of Ascorbate Oxidase. Ascorbate oxidase from
green zucchini squash was purified by slight modification of
the method of Lee and Dawson (9). As a starting material,
frozen ammonium sulfate precipitate (ca. 900 g), kindly pro-
vided by C. R. Dawson (Columbia University), was used; more
than 100 mg of purified protein was isolated having a spectral
purity ratio A250/A619 of 25.6 [literature value, 25.6 (14)]. Based
on E610 = 9600 M-1 cm-1 (13), a copper stochiometry of 8.2 per
140,000 daltons of enzyme (13) was determined by flame
atomic absorption using Chelex-treated 0.05 M sodium ace-
tate/0.1 M NaCl, pH 5.5, for both protein and copper standards.
Electrophoresis under nondenaturing conditions (30) revealed
only minute impurities; no impurities were seen with electro-
phoresis under denaturing (sodium dodecyl sulfate) conditions
(31).
General Procedures. Reagent grade chemicals were used
without further purification. Nitric oxide was obtained from
Union Carbide; and sodium fluoride was from Allied Chemicals
(Morristown, NJ).
Treatment of ascorbate oxidase in a quartz EPR tube with
nitric oxide was performed on a vacuum line using nitric oxide
passed through a dry ice/acetone bath to remove impurities.
Several gentle pump/purge cycles were carried out first with
argon to deoxygenate the protein, followed by several more
cycles with nitric oxide.
EPR spectra were run on a Varian E-line Century Series
spectrometer equipped with a Varian E-102 microwave bridge
and a 12-inch (30.5 cm) magnet. Frequencies were measured
with a PRD Electronics (New York) frequency meter. An Air
Abbreviations: EPR, electron paramagnetic resonance; CD, circular
dichroism.
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Products (Allentown, PA) Heli-Trans system was used to obtain
low temperatures.
All pH measurements were made at room temperature with
a Brinkman pH 101 meter equipped with a Metrohm (Herisau,
Switzerland) combination electrode. All experiments were done
with protein dissolved in 0.1 M sodium phosphate buffer (pH
7.0). Concentrated protein samples were obtained by ultrafil-
tration (Amicon) through a PM-30 membrane or by use of a
Millipore immersible molecular separator. EPR spectra were
measured on protein at approximately 0.6 mM. Details of the
operating conditions are given in the figure captions. The ap-
plication of EPR to the study of metalloenzymes has been re-
viewed by VWnngird (32), by Beinert and Palmer (33), and by
Fee (34).
RESULTS AND DISCUSSION
Coordination Environment of Type 2 Copper. The EPR
spectrum of-native ascorbate oxidase at pH 7.0 is displayed in
Fig. 1. Similar spectra have been reported by several labora-
tories (9-12, 28). Resolution of the type 1 copper hyperfine
splitting pattern is indicated. In contrast to ceruloplasmin,
where the two lowest field type 2 copper hyperfine lines are
clearly seen in the spectrum of the native protein (26), only a
slight broadening is seen in the 2800-2900 gauss region where
the second lowest field type 2 copper hyperfine line of ascorbate
oxidase is most likely located. Consequently, we have been
unable to resolve the type 2 copper hyperfine splitting pattern
as was done for ceruloplasmin (26) without use of computer
simulation.
Exposure of native ascorbate oxidase to nitric oxide under
anaerobic conditions led to a substantially simplified spectrum
(Fig. 2). Because essentially all of the type 1 EPR signal disap-
peared as a result of this procedure, it was possible to assign the
type 2 copper hyperfine pattern. Similar spectra of nitric
oxide-treated blue copper oxidases have been reported for as-
corbate oxidase (11), ceruloplasmin (26, 27, 35), and laccase
(20). As with nitric oxide-treated ceruloplasmin (26), the or-
dering of the g values (gjj > g1 > 2.0023) and the magnitude
of the copper hyperfine splitting (IA1 IAi 160 G) suggest a te-
tragonal copper coordination geometry for type 2 copper in the
modified protein.
Expansion of the go region (3100-300 G) reveals a weak
seven-line superhyperfine pattern (Fig. 2, curve B) not previ-
ously observed for ascorbate oxidase (11) but similar to results
obtained for ceruloplasmin (26, 35). Coordination by three
nitrogen-donor (I = 1) ligands is a reasonable interpretation of
FIG. 1. EPR spectrum of native ascorbate oxidase at 82 K and
9.1760 GHz. Power was 10 mW and modulation amplitude was 4
gauss.
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FIG. 2. EPR spectrum of nitric oxide-treated ascorbate oxidase.
Curve A: temperature, 80 K; frequency, 9.1740 GHz; power, 10 mW;
and modulation amplitude, 4 gauss. Curve B: temperature, 82 K;
frequency, 9.1740 GHz; power, 1 mW; and modulation amplitude, 4
gauss. The scale for A is at the top and for B is at the bottom.
the observed splitting; however, owing to the weak signal,
coordination by four such ligands cannot be ruled out. In regard
to the latter issue, we should point out that a nine-line su-
perhyperfine pattern indicative of four nitrogen-donor ligands
has been seen in the EPR spectrum of a type 1-depleted ceru-
loplasmin derivative (21). And electron spin echo experiments
on ceruloplasmin (36) as well as EPR data obtained for galactose
oxidase (the latter protein possesses a type 2-like copper) (37)
have suggested histidine coordination to type 2 copper. The
available evidence for ascorbate oxidase only allows us to
speculate by analogy that the nitrogen-donor ligands that are
indicated are also histidines.
Fluoride Binding. The anion binding properties of ascorbate
oxidase have only recently come under scrutiny. Mondovi et
al. (28) examined the effect of azide on the spectral and cata-
lytic properties of ascorbate oxidase and found changes in the
type 2 copper EPR signal upon addition of azide to the native
enzyme. They also found azide to be a noncompetitive inhibitor
with respect to ascorbate, in contrast with the earlier work of
Nakamura et al. (38) with ascorbate oxidase from cucumber
and with the later and more complete work of Strothkamp and
Dawson (29). As a result of their observations, Mondovi et al.
concluded that azide binds to type 2 copper but were unable
to reach any definite conclusions about the role of this inter-
action in the overall inhibition of enzyme activity.
Strothkamp and Dawson (29) examined the effects of fluo-
ride and cyanide, in addition to azide inhibition, on the optical
spectroscopy and enzymatic activity of the enzyme. For fluo-
ride and azide, they found competitive inhibition with respect
to ascorbate and noncompetitive inhibition with respect to
oxygen. The situation with cyanide was much more compli-
cated due to irreversible inactivation. Because fluoride had been
shown to bind to type 2 copper in laccase (39) and ceruloplas-
min (26, 40), by analogy they concluded that fluoride binds to
the type 2 copper of ascorbate oxidase. Consequently, based on
their evidence of competitive inhibition, they concluded that
the type 2 copper is an ascorbate binding site.
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FIG. 3. EPR spectrum of fluoride-treated (1000 equiv.) ascorbate
oxidase at 82 K and 9.1760 GHz. Power was 10mW and modulation
amplitude was 4 gauss.
In order to obtain direct evidence for fluoride binding to type
2 copper, we examined the effect of added fluoride (I = 1/2)
on the EPR spectrum of ascorbate oxidase. Exposure of the
enzyme to a large excess of fluoride ion resulted in a splitting
of the lowest field type 2 copper hyperfine transition into a
triplet with an intensity ratio of approximately 1:2:1 (Fig. 3).
Due to the overlap of the type 1 copper hyperfine lines in the
g region, which are unaffected by fluoride addition, splittings
can only be seen in the lowest field type 2 copper hyperfine line.
Therefore, we added nitric oxide to the fluoride-treated protein
in order to eliminate interference from the type 1 EPR signals
(Fig. 4). The appearance of triplets in the gII region of native
and nitric oxide-treated ascorbate oxidase in the presence of
fluoride ion indicates that two fluoride ions are bound to the
type 2 copper as has been demonstrated for laccase (39) and
ceruloplasmin (26, 40). This direct evidence for fluoride'binding
by type 2 copper in ascorbate oxidase provides considerable
support for the conclusion reached by Strothkamp and Dawson
(29) that the type 2 copper'is part of the ascorbate binding
site.
The data presented in this report on the fluoride binding and
coordination environment of type 2 copper in ascorbate oxidase
are similar to results obtained previously for ceruloplasmin (26).
The most reasonable conclusion that is consistent with all the
data is that the type 2 copper has a tetragonal geometry in-
cluding at least three equatorial nitrogen-donor ligands. This
type 2 site can accommodate up to two fluoride ligands. The
evidence obtained here for fluoride binding combined with the
fact that fluoride competitively inhibits ascorbate oxidase ac-
tivity (29) suggests that type 2 copper is an important site of
interaction of the substrate with the enzyme.
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